EP2838506
Magnesíumsamsetningar til að móta lyfjahvörf og lyfhrif insúlíns og insúlínhliðstæða og verki á inndælingarsvæði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.4.2013EP published:
6.1.2021EP application number:
13721441.7
EP translation filed:
25.3.2021Grant published:
15.4.2021EPO information:
European Patent Register
Max expiry date:
15.4.2033Expiry date:
15.4.2026Next due date:
30.4.2026
Title:
MAGNESIUM COMPOSITIONS FOR MODULATING THE PHARMACOKINETICS AND PHARMACODYNAMICS OF INSULIN, AND INJECTION SITE PAIN
Timeline
Today
16.4.2013EP application
6.1.2021EP Publication
25.3.2021Translation submitted
15.4.2021Registration published
15.4.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
POHL, RoderikeAddress:
Sherman, CT 06784, US
Name:
HAUSER, RobertAddress:
Columbia, MD 21045, US
Name:
LI, MingAddress:
Yorktown Heights, NY 10598, US
Name:
WILSON, Bryan R.Address:
Brewster, NY 10509, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261624844 PDate:
16.4.2012Country:
US
Number:
201261704066 PDate:
21.9.2012Country:
US
Number:
201313826806Date:
14.3.2013Country:
US
Classification
Categories:
A61P 3/10, A61K 9/00, A61K 38/28, A61K 47/02, A61K 47/12, A61K 47/18
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 24.3.2021
Expires: 15.4.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 22.3.2022
Expires: 15.4.2023
Payer: Patice ehf.
Number: 11
Paid: 25.3.2023
Expires: 15.4.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 20.3.2024
Expires: 15.4.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.4.2025
Expires: 15.4.2026
Payer: Árnason Faktor ehf.